ARX 1.79% 55.0¢ aroa biosurgery limited

poor TELA bio results, page-4

  1. 16 Posts.
    ARX's main issue is Brian Ward . Full stop . I have been a holder and accumulator since the IPO . Brian Ward is out of his depth in the highly competitive North American market .

 
watchlist Created with Sketch. Add ARX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.